Bionano reports first quarter 2025 results and highlights recent business progress

San diego, may 14, 2025 (globe newswire) -- bionano genomics, inc. (nasdaq: bngo) today reported financial results for the first quarter ended march 31, 2025. “the first quarter of 2025 represents the first full quarter of execution after shifting strategy towards a focus on our base of routine users of optical genome mapping (ogm) and via™ software as the primary drivers of our revenue and gross profit.
BNGO Ratings Summary
BNGO Quant Ranking